Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Malek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004
- Baylor College of MedicineResidency, Internal Medicine, 1997 - 2001
- University Hamburg, Krankenhaus Eppendorf, Fak MedClass of 1993
Certifications & Licensure
- MI State Medical License 2004 - 2026
- MD State Medical License 2001 - 2005
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphoma.Qiangqiang Shao, Karan Bedi, Isabella A Malek, Kerby Shedden, Sami N Malek
Leukemia. 2025-04-01 - Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk
Leukemia. 2025-01-01 - Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk
Leukemia. 2025-01-01
Grant Support
- Genes regulating stem and progenitor cell expansion and relapse in Acute Myeloid LeukemiaUNIVERSITY OF MICHIGAN AT ANN ARBOR2025–2030
- The Biology of Mutant STAT6 in Follicular LymphomaUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
- Genomic Complexity And Clinical Outcome In Chronic Lymphocytic LeukemiaNational Cancer Institute2009–2012
- Genomic Profiling And Clinical Outcome In Chronic Lymphocytic LeukemiaNational Cancer Institute2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: